Cardiac involvement in a patient with B-cell lymphoblastic lymphoma/acute lymphoblastic leukemia and a history of allogeneic hematopoietic stem cell transplantation and CAR T-cell therapy: A case report

被引:1
|
作者
Cao, Yigeng [1 ,2 ]
Liu, Yadan [3 ]
Zhang, Rongli [1 ,2 ]
Zhai, Weihua [1 ,2 ]
Ma, Qiaoling [1 ,2 ]
Wei, Jialin [1 ,2 ]
Yang, Donglin [1 ,2 ]
Pang, Aiming [1 ,2 ]
He, Yi [1 ,2 ]
Chen, Xin [1 ,2 ]
Jiang, Erlie [1 ,2 ]
Feng, Sizhou [1 ,2 ]
Han, Mingzhe [1 ,2 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol, Natl Clin Res Ctr Blood Dis, State Key Lab Expt Hematol,Haihe Lab Cell Ecosyst, Tianjin, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Blood Dis Hosp, Tianjin, Peoples R China
[3] Ningbo First Hosp, Ningbo Clin Res Ctr Hematol Malignancies, Hematol Dept, Ningbo, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2023年 / 13卷
关键词
B cell acute lymphoblastic leukemia; B cell lymphoblastic lymphoma; allogeneic hematopoietic stem cell transplantation; chimeric antigen receptor T cells; cardiac involvement; MANAGEMENT; DIAGNOSIS; NEOPLASMS;
D O I
10.3389/fimmu.2022.1052336
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cardiac involvement in hematological malignancies is uncommon, with only a few cases reported to date, and it often leads to a poor prognosis. Here, we report a case of a 42-year-old woman with a history of allogeneic hematopoietic stem cell transplantation (allo-HSCT) and anti-CD19 chimeric antigen receptor (CAR) T-cell therapy for B-cell lymphoblastic lymphoma/acute lymphoblastic leukemia in whom cardiac mass and myocardial infiltration were detected. Prior to this presentation, massive pericardial effusion had occurred 6 months after CAR T-cell therapy, which was improved via ultrasound-guided pericardiocentesis. We observed elevated cytokine levels and increased copy number of CAR DNA in both pericardial effusion and serum. Upon detecting cardiac mass and myocardial infiltration, the patient was administered tocilizumab (a humanized monoclonal antibody against IL-6 receptor), which controlled the serum cytokine levels, and reduced intensity chemotherapy, including vindesine, cyclophosphamide, and prednisolone. However, the patient finally died of multiple organ failure. To the best of our knowledge, this is the first report on the development of a cardiac mass and occurrence of myocardial infiltration after allo-HSCT and CAR T-cell therapy. This report may provide supporting data for the early diagnosis and immediate treatment of patients with cardiac involvement.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] CAR T-Cell Therapy in Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia/Lymphoma: A Retrospective Study
    Zhao, Liping
    Zhou, Qi
    Chen, Chen
    Ling, Zhuojun
    Wang, Kai
    Wu, Fan
    Xu, Jinlong
    Duan, Jiajia
    Wang, Zelin
    Wang, Quangang
    Pan, Jing
    BLOOD, 2023, 142
  • [42] Pegaspargase, venetoclax, and nelarabine: a successful bridge to allogeneic hematopoietic stem cell transplantation in a relapsed/refractory T-cell acute lymphoblastic leukemia patient
    Kaya, Sureyya Yigit
    Bektas, Sebnem
    Askin, Abdullah Emre
    Aydin, Berrin Balik
    Mutlu, Yasa Gul
    Sevindik, Omur Gokmen
    ANNALS OF HEMATOLOGY, 2023, 102 (06) : 1599 - 1600
  • [43] Pegaspargase, venetoclax, and nelarabine: a successful bridge to allogeneic hematopoietic stem cell transplantation in a relapsed/refractory T-cell acute lymphoblastic leukemia patient
    Süreyya Yiğit Kaya
    Sebnem Bektas
    Abdullah Emre Askin
    Berrin Balık Aydın
    Yaşa Gül Mutlu
    Ömür Gökmen Sevindik
    Annals of Hematology, 2023, 102 : 1599 - 1600
  • [44] Case Report on Acute Lymphoblastic Leukemia B-Cell
    Sakharwade, Prerana
    Watmode, Ankita
    Kurian, Bibin
    Meshram, Khushbu
    Kolhekar, Sonali
    Sawarkar, Achita
    Shambharkar, Madhuri
    Tembhare, Vaishali
    JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2021, 33 (49B) : 39 - 44
  • [45] Adoptive T-cell therapy for B-cell acute lymphoblastic leukemia: preclinical studies
    Cardoso, AA
    Veiga, JP
    Ghia, P
    Afonso, HM
    Haining, WN
    Sallan, SE
    Nadler, LM
    BLOOD, 1999, 94 (10) : 3531 - 3540
  • [46] Cutaneous aspergillosis in an acute lymphoblastic leukemia patient after allogeneic hematopoietic stem cell transplantation
    Tunccan, G. Ozlem
    Aki, A. Sahika Zeynep
    Akyurek, A. Nalan
    Sucak, S. Gulsan
    Esin, S.
    MYCOSES, 2009, 52 : 81 - 81
  • [47] Perspectives on outpatient administration of CAR-T cell therapy in aggressive B-cell lymphoma and acute lymphoblastic leukemia
    Myers, G. Doug
    Verneris, Michael R.
    Goy, Andre
    Maziarz, Richard T.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (04)
  • [48] OUTCOMES OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOLLOWING BLINATUMOMAB IN CHILDREN AND YOUNG ADULTS WITH B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
    Algeri, Mattia
    Massa, Michele
    Galaverna, Federica
    Pagliara, Daria
    Pili, Ilaria
    Del Bufalo, Francesca
    Becilli, Marco
    Boccieri, Emilia
    Carta, Roberto
    Quagliarella, Francesco
    Rosignoli, Chiara
    De Luca, Carmen Dolores
    Lucarelli, Barbarella
    Merli, Pietro
    Locatelli, Franco
    BONE MARROW TRANSPLANTATION, 2024, 59 : 151 - 152
  • [49] T-CELL AND B-CELL MARKERS IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
    MASSIMO, L
    PASINO, M
    ROSANDA, C
    TONINI, GP
    ASTALDI, A
    PEDIATRIC RESEARCH, 1976, 10 (10) : 896 - 896
  • [50] Hypereosinophilia in biphenotypic (B-cell/T-cell) acute lymphoblastic leukemia
    Bae, Sook Young
    Yoon, Soo-Young
    Huh, Ji Hoon
    Sung, Hwa Jung
    Choi, In Keun
    LEUKEMIA & LYMPHOMA, 2007, 48 (07) : 1417 - 1419